Why Credit Suisse Is Betting on These Five Rebound Stocks

By

Apr. 26 2021, Updated 11:14 a.m. ET

While the U.S. economy is expected to rebound sharply in 2021 as it emerges from the slump in 2020, there are also concerns about markets getting overheated. In 2020, there were concerns about growth stocks getting overheated. Now, a section of the market is concerned about the steep rise in value stocks. Credit Suisse has identified rebound stocks that will benefit from the rapid expansion of the U.S. economy. Should you own any of these?

Article continues below advertisement

For almost a decade, growth stocks have outperformed value stocks. Now, with the U.S. economy expected to grow at the strongest pace in years, investors have poured money into defensive names, which has led to a rally in these stocks.

Credit Suisse cyclical defensives

Cyclical stocks tend to be more volatile than the broader markets and their fortunes are closely tied with the economic activity. These names took a beating in the first half of 2020. The COVID-19 pandemic took a toll on the global economic activity as well as cyclical companies' revenues and profitability.  

Article continues below advertisement

Credit Suisse is cautious on cyclical names amid concerns about their valuations getting stretched. The sharp rebound in the U.S. and the global economy is coming from the bottoms that we hit in 2020, so the growth isn't sustainable.

Article continues below advertisement

Credit Suisse is bullish on some of the defensive names which it thinks can benefit from the strong economic growth. These stocks are also expected to benefit in an inflationary environment.

Article continues below advertisement

Credit Suisse rebound stock list

Credit Suisse has identified five stocks that it thinks could outperform in the current macro environment. The stocks include:

  • Universal Health Services (UHS)
  • Laboratory Corporation of America Holdings (LH)
  • HCA Holdings (HCA)
  • Patterson Companies (PDCO)
  • Constellation Brands (STZ)

Four of these companies are in the healthcare space and only Constellation Brands is a non-healthcare name in Credit Suisse's rebound stock list.

Article continues below advertisement

Looking at the individual stocks, Universal Health Services and HCA Holdings are hospital chains. In 2020, elective surgeries were barred in many jurisdictions. Most of the medical infrastructure went towards the COVID-19 pandemic. Given the impressive pace of COVID-19 vaccinations, we could see a rebound in optional procedures in 2021 due to the pent-up demand.

Laboratory Corp also got a buy rating from Credit Suisse analysts. The company benefited from increasing COVID-19 testing. According to the estimates compiled by TipRanks, LH stock has an average target price of $279.38, which is a premium of around 6 percent over the current prices.

Article continues below advertisement

Constellation Brands is a producer and marketer of beer, wine, and other alcoholic beverages. According to the estimates compiled by CNN Business, Constellation Brands has a median target price of $262, which is a 7 percent premium over the current prices.

Article continues below advertisement

Along with these five stocks, Credit Suisse is also bullish on utility companies that have their pricing linked to inflation.

Best companies to invest in recovery

Looking at the uptrend in the economy, there are several recovery stocks worth considering. Rolls-Royce (RYCEY) looks like a good beaten-down stock that you can buy to play the recovery. Disney is also a play on the recovery as its theme parks reopen. Hotel stocks like Marriott and Hilton are also good recovery plays.

Advertisement

More From Market Realist

  • Equinox gym
    Fund Managers
    Should You Buy Palihapitiya’s IPOF Stock on Equinox Merger News?
  • Chamath Palihapitiya and Bill Ackman
    Fund Managers
    PSTH, IPOD, or IPOF: Which SPAC Is Worth a Buy Now After the Crash?
  • ARK Invest CEO Cathie Wood posing with a car
    Fund Managers
    Cathie Wood Is Buying These Under the Radar Stocks— But Should You?
  • Social Capital CEO Chamath Palihapitiya
    Fund Managers
    Rise in Clover Health Stock Might Lift Other Palihapitiya SPACs
  • CONNECT with Market Realist
  • Link to Facebook
  • Link to Twitter
  • Link to Instagram
  • Link to Email Subscribe
Market Realist Logo
Do Not Sell My Personal Information

© Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.